mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.05 |
mRNA |
BI-2536 |
FIMM |
pan-cancer |
AAC |
-0.26 |
0.05 |
mRNA |
JQ-1:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.05 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.05 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.05 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
Sunitinib |
FIMM |
pan-cancer |
AAC |
0.34 |
0.06 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
0.066 |
0.06 |